PATENT CLAIM ANALYSIS

Application Number: 15939143
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["424", "448000"]

Abstract:
In one embodiment, a transdermal patch includes a substrate and a layer of pressure-sensitive adhesive provided on the substrate, the pressure-sensitive adhesive comprising a blend of an adhesive compound and a carrier-drug compound, the carrier-drug compound comprising a drug transport compound and a drug that is to be delivered to the skin of a subject, wherein the drug transport compound transports the drug through the pressure-sensitive adhesive to the skin

Claim (Index 10):
The patch of  claim 1 , wherein the drug comprises fentanyl, buprenorphine, aspirin, acetaminophen, lidocaine, bupivacaine, nitroglycerin, paclitaxel, estradiol, ethinyl estradiol, estrogen, nicotine, clonidine, fentanyl, fentanyl hcl, scopolamine, testosterone, epinephrine, norethindrone, norelgestromin, levonorgestrel, oxybutynin, tetracaine, methylphenidate, selegiline, rotigotine, rivastigmine, menthol, methyl salicylate, methyphenidate transdermal vitamin B12, 5-Hydroxytryptophan, lorazepam, diphenhydramine, haloperidol, paclitaxel, sumatriptan, stilboestrol, sufentanil, or a mixture thereof.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 90.0
- Lexical Diversity: 2.17647
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12894512', '14863688', '12309226', '15227214', '11194157']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7432252491227395
- 35 USC 102 Novelty (BERT): 0.4683320601487798
- Combined Prediction Score: 0.7157359302253434
- Mean Citation Score: 175.264156
- Max Citation Score: 180.1923
- Similarity Product: 145.80464743629096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test